
|
Categories:
Topics:
Tools
Selected articles
Winning an Oscar in immunologyFeatured on frontpage?: no
When my phone rang and I was told that our article was to be published in Nature Immunology (Ribot et al, 2009), I just couldn’t stay put. But even though a few people around me understood my hysterics, I had to explain to many others what this really meant for us: “It’s like an actor receiving an Oscar!” Our particular Oscar was not for best film, actor or soundtrack, but for a discovery in immunology. Having our work published in this prestigious journal meant that fellow scientists had deemed it noteworthy, and that others would now be able to learn from it and build upon it towards the common goals of understanding how our bodies fight disease and subsequently improving human medicine. Sitting on my shelf, ‘our’ issue may look like just another magazine, but it means as much to me as a trophy in a display cabinet. The subject of our research is the development of a type of white blood cell, called a T lymphocyte or T cell, in the thymus. T lymphocytes are distinguished from other lymphocytes by a molecule on their surface called a T-cell receptor, which recognises the antigen carried by a specific invader, such as a bacterium or virus.
The two cytokines IFNγ and IL-17 play an important role in the immune response, with very distinct consequences: those T cells producing IFNγ will play a crucial role in fighting viruses and tumours, whereas those producing IL-17 are associated with autoimmune diseases such as multiple sclerosis. Mice without CD27 suffered less from cerebral malaria, probably because they produce less IFNγ, which is involved in inflammation (see lower diagram above). Whether this finding could be used in the development of future malaria drugs – perhaps by manipulating the expression of CD27, so that the cells produce lower levels of pro-inflammatory cytokines – remains to be seen.
We still have a lot of work ahead of us, but this recognition of what we have already achieved reminds us that it is all worth it. Long after I had hung up the phone, then finished explaining my excitement, I still couldn’t stop smiling. References Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ, Girardi M, Borst J, Hayday AC, Pennington DJ & Silva-Santos B (2009) CD27 is a thymic determinant of the balance between interferon-g and interleukin 17-producing gd T cell subsets. Nature Immunology 10: 427-436. doi:10.1038/ni.1717 Web references w1 – Find out more about the Instituto de Medicina Molecular in Lisbon here: www.imm.fm.ul.pt Resources To learn more about malaria, see:
To browse previously published cutting-edge articles in Science in School, see: www.scienceinschool.org/cuttingedge
Ana de Barros was born in Lisbon in 1983, and at the age of 19 moved to Newcastle, UK, where she graduated in genetics. She then stayed in the UK to do an MSc in biomolecular archaeology in Manchester. After working for 3 months in a lab in Athens, Greece, doing stem cell research, Ana went back to Portugal in 2007, where she started her PhD in immunology at the Instituto de Medicina Molecular in Lisbonw1. She is interested in scientific journalism, as is brings together communication and science. Outside the lab, she is very involved in the arts and has a band where she plays the guitar, writes songs and sings. Ana also does a lot of photography and enjoys travelling. Review Immunology is still a fast-moving subject as more is discovered about the involvement of the different types of cells and signalling molecules. Cerebral malaria in humans is currently very difficult to treat. A specific subtype of T cells and the signalling molecule CD27 are involved in the progress of cerebral malaria in mice and this research may have implications for the treatment of this disease in humans. Using this article for background information may stimulate discussion on malarial treatment and eradication, basic immunology, genetic manipulation of mice and whether animal experimentation is right. It could be used for comprehension with further questions set to probe students’ understanding of immunology at the upper secondary level. Shelley Goodman, UK
|